Loading clinical trials...
Loading clinical trials...
Clevidipine for Acute High Blood Pressure Control in Neurocritical Patients
Acute blood pressure elevation is a frequent problem in neurocritical patients. Its effective management is challenging and must avoid significant decreases of blood pressure leading to lower cerebral perfusion pressure worsening ischemia and elevations probably associated with bleeding, rebleeding or hematoma expansion associated with poor prognosis
Retrospective, observational and single-group study for observe effectiveness and safety of clevidipine for perioperative control of hypertension in patients admitted to Post-Operative Intensive Care Unit after thrombectomy for stroke, intracerebral hemorrhage requiring surgical treatment, embolization of aneurysm after subarachnoid hemorrhage, scheduled neurosurgical and neuroradiology procedures.
Age
All ages
Sex
All
Healthy Volunteers
No
Biocruces
Barakaldo, Vizcaya, Spain
Start Date
January 1, 2017
Primary Completion Date
December 31, 2018
Completion Date
September 1, 2019
Last Updated
December 23, 2021
33
ACTUAL participants
Clevidipine 0.5 MG/ML Intravenous Emulsion
DRUG
Lead Sponsor
Hospital de Cruces
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06143566